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It is assumed that sarcoidosis is caused by inhalation of air borne agents in susceptible persons triggering the
inflammatory reaction. The association of metallic dust exposure, such as beryllium and aluminium, and sarcoidlike
pulmonary disorders is well known. The ability of man-made mineral fibres (MMMF) to cause granulomatous lung
disease has not been appreciated until now. Recently, we observed the association of sarcoidlike granulomatous
reaction and occupational history of glass fibre exposure. We hypothesized that there might be a relationship
between MMMF exposure and the development of sarcoidlike granulomas. Therefore, the records of 50 sarcoidosis
patients—who visited our outpatient clinic between 1996 and 1999—were reviewed. This revealed that 14 cases
recalled a history of exposure to either glass fibres or rock wool, both MMMF fibres. The available obtained tissue
specimens (n=12) were reviewed. In six cases electron microscopy qualitative analysis of small fragments of the
tissue revealed among others silica, aluminium and sometimes titanium. A distinct relation between fibre deposits
fibre deposits and granulomas was found. These findings indicate that in susceptible people MMMF exposure
might be related to a chronic granulomatous disease similar to chronic beryllium disease.
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Although the cause(s) of sarcoidosis remain unknown,
there are lines of evidence supporting the idea that
sarcoidosis results from exposure of genetically susceptible
hosts to specific environmental agents triggering the
inflammatory reaction (1). Several infectious organisms
such as viruses, Proprionibacterium acnes and mycobacteria
have been implicated as potential causes of sarcoidosis.
Also, non-infectious inorganic and organic environmental
agents can elicit a granulomatous response with many
features that are similar to sarcoidosis (1).
The association of metallic dust exposure, such as
beryllium and sarcoidlike pulmonary disorders is well
known (1,2). Similar manifestations are occasionally
reported in relation to other metal dust exposures, such
as aluminium, zirconium, titanium, earth metals (or
lanthanides, such as cerium) and talc which contains—Received 15 December 1999 and accepted in revised from 15 March
2000.
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and silica (1,3–7). As many oxidative agents, infectious and
(in)organic, may trigger the granulomatous response in
susceptible individuals (1–7), it is highly likely that there is
no single cause of sarcoidosis. Therefore, the search for any
possible relevant exposure of a patient with suspected
sarcoidosis seems mandatory.
Recently, we observed the presence of sarcoidlike
granulomas within a patient with an occupational history
of glass fibre exposure (8). This association prompted us to
evaluate whether exposure to certain MMMF, such as rock
wool or glass fibres, may elicit a granulomatous response
similar to sarcoidosis.
Materials and methods
STUDY POPULATION
The records of 50 sarcoidosis patients—who visited our
outpatient clinic between 1996 and 1999—were reviewed.
All cases were asked for their medical history, with
particular reference to any occupational and/or environ-
mental exposure. This screening revealed that 14 cases had
a history of exposure to either rock wool or glass fibres# 2000 HARCOURT PUBLISHERS LTD
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exposure and the development of sarcoidlike granulomas,
the clinical records and tissue specimens of these sarcoidosis
patients were reviewed carefully. Of these 14 patients 12
biopsy specimen were available.
PULMONARY FUNCTION TESTS
Pulmonary function measurements included the forced
expiration volume in 1 sec (FEV1) (Compactbody, Jaeger,
Wu¨rzburg, Germany). The best measure of three eorts was
selected. All volumes are expressed as percentages of the
reference values (9). The diusing capacity for carbon
monoxide (DLCO) was measured using the single-breath
method (Masterlab, Jaeger, Wu¨rzburg, Germany). Values
were expressed as a percentage of those predicted (9).
EXERCISE CAPACITY
Patients performed a symptom limited incremental exercise
test on an electronically braked cycle ergometer (Cornival
400, Lode, Groningen, The Netherlands). After a period of
rest and 2min of unloaded pedalling, a progressively
increasing work rate test was started in order to determine
peak work rate (W peak) and oxygen uptake (VO2 peak) of
the subject. The work rate increase was set at 10 W min71
for each patient and 15–30Wmin71 for the healthy
volunteers, depending upon their training status. Pedal
frequency was selected by the subjects between 60 and 70
rpm and held constant throughout the test. Breath-by-
breath gas exchange was measured throughout the test by a
ventilated hood system (Oxyconbeta, Jaeger, Bunnik, The
Netherlands). An infrared electrode was placed on a finger
to measure oxygen saturation (Fasttrac, Sensor Medics
Co., Anaheim, California, U.S.A.). Heart rate was mea-
sured throughout the test using a sport tested (PE3000,
Polar Electro cy, Kempele, Finland). In rest and during
maximal exercise arterial blood samples were taken and
arterial blood gas analyses were performed.
CHEST RADIOGRAPHS
Chest radiographs were made in the posterior–anterior and
lateral projections, and were classified by a single experi-
enced reader, blinded to the patients’ clinical history, in
a standard manner according to the radiographic stage
(0 to IV).
HIGH-RESOLUTION COMPUTED
TOMOGRAPHY
Thin section scans with 1 mm collimation were obtained at
10-mm intervals through the chest. The scanning para-
meters included 137 kVp, 255 mA, and 1-sec scanning time.
Both mediastinal (width, 400 HU; level, 40 HU) and lung
(width, 1600 HU; level, 7800 HU) window images were
obtained. Scans were reconstructed with a high-frequency
reconstruction algorithm. A single experienced reader,blinded to the patient’s clinical history classified the scans.
The typical patterns of parenchymal involvement were
qualitatively registered as thickening or irregularity of the
bronchovascular bundle (BVB), intraparenchymal nodules
(ND), septal and non-septal lines (LS) and parenchymal
consolidation (including ground glass opacifications) (PC)
as well as the volume aected which was quantified by a
visual score: 0 no lesions found; 1=up to 33%; 2=up to
66%; 3=more than 66% of the volume aected. Similarly,
the quantification of the focal pleural thickening (PL)
respectively the enlargement of the lymph nodes (LN) was
done: 0=no pathological findings, 1=minor, 2=moderate,
and 3=pronounced changes (10). The total score was
obtained by counting the individual scores (BVB, ND, LS,
PC, LN and PL) together.
X-RAY ANALYSIS
The presence of MMMF in the biopsy specimen was
evaluated by qualitative X-ray microanalysis in small
fragments of tissue. X-ray energy dispersive microanalysis
is based on the interaction of accelerated electrons with
inner orbital electrons of an atom. Some of these inner
electrons are ejected and the hole is filled by an electron
from a shell of higher energy, resulting in X-ray radiation
(peaks) characteristic for shells transversed. X-ray analysis
provides a qualitative analysis of the chemical composition
of the scanned area (either the present foreign body or the
control area without any foreign body) generating multiple
peaks (11). Lung tissue or lymph node biopsy specimens,
embedded in paran, were rehydrated and fixed in
glutaraldehyde, in some cases post-fixed in osmiumtetra-
oxide (OsO4), dehydrated in graded series of ethanol and
embedded in Epon 812 (Agar Scientific Ltd, Stansted,
Essex, U.K.). Ultra thin sections (60 nm) were observed at
120 kV in a Philips CM 12 electron microscope (Philips
Eindhoven, The Netherlands) and analysed with an EDAX
pv9900 system (Philips Eindhoven, The Netherlands). The
analysed area, a small spot (25 mm) exactly covering the
foreign body, was scanned (rectangular pattern; n=7) and a
similar area adjacent to this foreign body used for back-
ground determination. The volume analysed of the area
with or without a foreign body was similar, e.g. +04 mm3.
The target area was an identified foreign body within a
granuloma of the lung tissue obtained from an exposed or
an area of lung tissue without the presence of any foreign
body.
STATISTICAL ANALYSIS
The data of the exposed sarcoidosis patients (group I) and
non-exposed patients (group II) were compared using one
way analyses of variance (ANOVA) for ordinal values and
w2-tests for nominal values. In all tests a probability value
of less than 005 was considered to be statistically
significant. All analyses were performed using the Statistical
Package for Social Science (SSPS) for Windows.
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Job histories and exposure estimates diered. Upon further
questioning six patients recalled that they worked — or had
worked in the past — in the same rock wool factory at the
same plant prior to the presentation of sarcoidosis, whereas
two patients processed rock wool for many years.
Additionally, six patients had a history of occupational or
environmental glass wool exposure. None of these cases
used dust masks or any other protection to reduce inhaling
amounts of dust consisting of MMMF. So, 14 cases
appeared to have a history of exposure to MMMF (group
I). The remaining 36 (group II) cases did not remember any
exposure to MMMF. The personal, clinical and laboratory
characteristics are summarized in Table 1. The mean serum
ACE levels, CRP levels, calcium as well as uric acid levels
were more or less increased compared to the reference
values (Table 1). Furthermore, a non-specific elevation of
serum immunoglobulins was noted in seven cases in group
I. Cellular bronchoalveolar lavage fluid (BALF) analysis
revealed a profile similar to sarcoidosis with an increased
total cell count, predominantly lymphocytes (12). The CD4/
CD8 ratio appeared to be 34+38 in group I and 47+36
in group II, respectively. No statistical dierences were
found regarding the cellular and non-cellular BALF
analysis results between both groups.
In group I, pulmonary function test results demonstrated
mild decreased mean values (60–80%) according to the
American Medical Association classes. Three cases ap-
peared to have a moderate decrease (40–60%). Desatura-
tion during exercise was found in eight cases (571%) of
group I compared to 10(277%) of group II.TABLE 1. Summary of personal and clinical characteristics of th
fibres (group I) and the non-exposed sarcoidosis cases (group I
Age (years)
Gender (male/female)
Smoking (yes/never/past)
Time elapsed since diagnosis sarcoidosis (years)
Exposure to rock wool/glass fibres
Exposure time (years)
Radiographic stage 0/I/II/III/IV
HRCT total score
SACE Ul71 (9–25)*
C-reactive protein mg l71 (2–9)*
Calcium mmol 171 (210–260)*
Uric acid mmol l71 (020–042)*
FEV1 (% predicted)
FVC (% predicted)
DLCO (% predicted)
Desaturation during exercise (yes/no)
Data are expressed as mean with standard deviation in parent
serum angiotensin converting enzyme; DLCO: diusing capaci
1 sec; FVC: forced vital capacity; *Reference ranges.All patients suered from fatigue, dry cough, dyspnoea
on exertion, chest pain and, occasionally, arthralgias,
weight loss, night sweats and fever. Based on the
presumptive diagnosis and more or less severity of the
disease at presentation—indicated by the pulmonary
function test results, presence of desaturation during
exercise, and imagining features (Table 1)—all patients
group I and 11 (305%) of group II were treated with
prednison orally. However, substantial disease relapses
occurred after tapering-o the corticosteroids. Therefore,
this treatment had to be continued in most cases (13 cases
from group I (928%) and seven cases from group II (194).
In four cases of group I and one case of group II the initial
improvement in symptomatic and pulmonary function tests
was not sustained despite corticosteroid treatment. The
radiological findings as well as the pulmonary function
parameters deteriorated. Therefore, in four of these cases
(group I; n=3 and group II; n=1) cyclophosphamide
(100mg daily) was started, whereas in one case of group II
methotrexate (15mg orally once a week) was given. Follow-
up of respiratory symptoms and related clinical features
revealed that the non-treated patients of group II (n=25)
recovered spontaneously (n=18) or did not deteriorate
(n=7), in contrast to none of group I.
The available obtained tissue specimens of group I
(n=12), either lung biopsy specimen (n=11) or mediastinal
lympth nodes (n=1), were reviewed. In all lung biopsy
slides the main component was a submucosal, interstitial
and occassionally subpleural located non-confluent non-
necrotizing granulomatous inflammation. In some granu-
lomas multinucleated giant cells of Langerhans or foreign
body type were present.e 14 studied sarcoidosis cases exposed to man-made mineral
I; n=26)
Group I Group II P-value
425(103) 411(128) n.s.
12/2 16/20 5001
0/11/3 5/21/7 n.s.
4(35) 2(25) n.s.
8/6 not known
28(45) —
0/0/2/10/2 5/7/16/6/1 5001
72(29) 36(28) 5002
235(121) 244(81) n.s.
191(175) 124(148) n.s.
276(008) 241(009) 002
053(009) 033(009) 5001
742(162) 900(167) 5001
793(166) 983(212) 5002
714(142) 856(199) 005
8/6 11/25 001
heses or numbers if appropriate; n.s: not significiant; SACE:
ty for carbon monoxide; FEV1: forced expiration volume in
FIG. 1. (a) Energy-dispersive X-ray spectrum from a fibre
determined in a lung biopsy specimen of a patient exposed
to glass fibres showing peaks for Mg (1253 keV), Al
(1486 keV) and Si (1,740 keV). The peaks for S and Cl
originate from the supporting material. (b). Energy-
dispersive X-ray spectrum from a similar area in the lung
biopsy specimen adjacent to this fibre [see (a)] used for
background determination.
FIG. 2. (a) Energy-dispersive X-ray spectrum from a fibre
determined in a granuloma present in a lung biopsy
specimen of a patient exposed to rock wool showing peaks
for Mg (1253 keV), Al (1486 keV), Si (1740 keV),
K(3313 keV), Ca (3691 keV), Ti (4509 keV) and Fe
(6899) keV. The peaks for S and Cl originate from the
supporting material. (b) Energy-dispersive X-ray
spectrum from an original rock wool fibre.
818 M. DRENT ET AL.The additional performed electron microscopy qualita-
tive analysis of small fragments of the granulomas over a
‘foreign body’ revealed among others silica, aluminium and
sometimes titanium [Fig. 1(a) and Fig. 2(a)]. This spectrum
diered from the lung tissue without foreign body deposi-
tion [Fig. 1(B)]. Figure 2(B) shows the spectrum of an
original rock wool fibre.
Discussion
Review of the occupational history of 50 cases with
sarcoidosis revealed exposure to MMMF in 14 cases.
Energy dispersive analysis of seven biopsy specimen
revealed silica, aluminium and titanium, which are elements
of MMMF [Fig. 2(B)]. A distinct relation between fibre
deposits and granulomas was found. Therefore, we
assumed that we identified a potential occupational
environment, such as MMMF, that confers risk for
sarcoidosis in persons with a certain (genetic) susceptibility.
The development of a specific lymphocyte proliferation
test—such as the beryllium specific lymphocyte prolifera-tion test—would add weight to confirm this hypothesis.
However, it is very dicult to develop such a test as
MMMF contain various elements including aluminium,
silica and titanium. Possibly, skin tests may provide specific
reactive IgE antibodies. Furthermore, HLA typing may
enable to identify a possible genetic suscepibility. More-
over, information regarding the number of workers at the
plant who might have been exposed, as well as the total
number of workers who finally develop a sarcoid-like
disorder is important in justifying the hypothesis. Future
research should be conducted in a cohort of MMMF-
exposed workers and control cohort to identify the
frequency of sarcoidosis in both populations.
A survey of workers in MMMF production plants
conducted by Hughes et al. revealed no clinical relevant
respiratory health eects (13). Occassionally, the associa-
tion of MMMF exposure and the development of
pulmonary fibrosis has been reported (14–16). However,
the ability of MMMF to cause granulomatous lung disease
was not appreciated until now (16). Assumably, the
granulomas disappear when the disease progresses towards
fibrosis. The association of exposure to foreign bodies with
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with helper T-cell alveolitis was considered by others
(17). The morphological pattern of these granulomas is
indistinguishable from the non-necrotizing granulomas
occurring in sarcoidosis. Day et al. suggested that the
inflammatory response induced by the presence of minerals
within the tissue may trigger altered immunoregulation,
accounting for the pathological changes (18). Metallic dust
may act as antigen in a hypersensitivity reaction (2–7).
Jacket et al. installed glasswool fibres within the lung of
Wistar rats. Additionally, they observed a non-specific
accumulation of macrophages in the alveoli and occasion-
ally a granulomatous reaction (19). Studies performed to
assess cytotoxicity, inflammatory and/or fibrogenic re-
sponse, suggested that DNA damage could also be
attributed to the production of hydroxyl radicals, which
results from the interaction of metallic dust with the cell
plasma membrane (2). The MMMF surface also may be
involved in hydroxyl radical production, and therefore be a
potential oxidative stress factor causing an uneven balance
between free radical generation and scavenging reactions
(20). Gilmour et al., showed the ability of MMMF to
generate free radicals at the fibre surface (21). Moreover,
Driscoll et al. described the activation of NF-kB by a range
of pneumoconiotic particles (22). Recently, we demon-
strated NF-kB activation in sarcoidosis (23). In line with
these observations, refracting ceramic fibres have been
reported to stimulate rat alveolar macrophages to release
tumour necrosis factor. The detection of surface hydroxyl
radical activity in a test fibre of unknown toxicity provides
support for the contention that the fibre is toxic; however,
failure to detect free radical activity cannot be taken as
evidence for non-toxicity (24,25).
Insulation wools contribute more than 80% to the total
MMMF production, they are used for thermal and
acoustical insulation, for fire protection, in acoustic ceiling
tiles and panels, in the manufacture of airconditioning and
ventilation ducts and as growing media for horticulture
(14). MMMF are manufactured from molten glass, rock,
slag, kaolin clay or combinations of silicon and aluminium
oxide.
The concentration of fibres in air, chemical composition
and size of fibres must be considered in evaluation of
potential health risks. To reach the alveolar space, fibres
must have certain dimensions (510mm, aerodynamics)
(14). The research concerning the pathogenesis of fibrosis
due to MMMF such as glass fibres and rock wool, has
focused on fibre dimensions, surface qualities and bioper-
sistence. In a few studies the pathogenic properties of
MMMF were related to their accumulation and to their
persistence as fibres in target organs (13,15). This is actually
a major field of concern in the evaluation of MMMF
toxicity, since it is likely that these fibres are not rapidly
cleared or dissolved in the lung. Ransson et al., indicated
a relationship between sarcoidosis and exposure to the
crystalline silica, cristobalite (26). Barbazza et al. suggested
that the development of granulomas after inhalation of
silica particles was not dependent on the amount of
silica, but is an individual cellular response (27). There is
good circumstantial evidence, particularly from berylliumworkers, that an exuberant granulomatous response to
organic and inorganic stimuli requires some form of host
predisposition. Moreover, chronic beryllium disease oc-
curred at both high and low levels of exposure, without a
clear association between magnitude of exposure and
disease incidence (2). Presumably, not only the quantity
of the exposure (amount of exposure), but also the quality
of the fibres (fibre components) provoked the granuloma-
tous reactions in genetically susceptible persons. Richeldi
et al. found that in a beryllium-exposed population carrying
the HLA-DPB1 Glu marker was associated with an eight-
fold increase in the rate of disease in the group of workers
with a history of higher exposure. Therefore, genetic as well
as exposure factors may have an additive or multiplicative
eect. Morever, the berylliosis model indicates genetic
studies are useful in determining exposure-related risk levels
for the genetically susceptible segment of the population
(28). These observations may have serious implications as
presently sucient protection during exposure to MMMF
are lacking, and many people—aware or unaware—are
exposed to these fibres.
In conclusion, MMMF are of risk to elicit a sarcoidlike
granulomatous response. Obviously, the progression from
MMMF exposure to disease hinges partly on an indivi-
dual’s genetic susceptibility. It is tempting to speculate that
to provoke a granulomatous reaction — like in hypersensi-
tivity pneumonitis and berylliosis — not the amount of
exposure but the components of the fibres are important.
The presented findings, together with previous observa-
tions, highlight that studies assessing the potential risk of
MMMF focused on the chemical composition as well as the
fibre size or shape and free radical production to cause a
granulomatous response are thoroughly needed, in addition
to genetic screening.
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